Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.

Bihl F, Berger C, Chisholm JV 3rd, Henry LM, Bertisch B, Trojan A, Nadal D, Speck RF, Flepp M, Brander C, Mueller NJ; Swiss HIV Cohort Study.

AIDS. 2009 Sep 10;23(14):1918-22. doi: 10.1097/QAD.0b013e3283300a91.

2.

Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft.

Loggi E, Bihl F, Chisholm JV 3rd, Biselli M, Bontadini A, Vitale G, Ercolani G, Grazi GL, Pinna AD, Bernardi M, Brander C, Andreone P.

J Hepatol. 2009 Mar;50(3):625-30. doi: 10.1016/j.jhep.2008.08.026. Epub 2008 Dec 25.

3.

Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.

Bihl F, Loggi E, Chisholm JV 3rd, Biselli M, Morelli MC, Cursaro C, Terrault NA, Bernardi M, Bertoletti A, Andreone P, Brander C.

Liver Transpl. 2008 Apr;14(4):478-85. doi: 10.1002/lt.21384.

4.

Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance.

Yerly D, Heckerman D, Allen TM, Chisholm JV 3rd, Faircloth K, Linde CH, Frahm N, Timm J, Pichler WJ, Cerny A, Brander C.

J Virol. 2008 Mar;82(6):3147-53. doi: 10.1128/JVI.02252-07. Epub 2008 Jan 9.

5.

Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.

Bihl F, Mosam A, Henry LN, Chisholm JV 3rd, Dollard S, Gumbi P, Cassol E, Page T, Mueller N, Kiepiela P, Martin JN, Coovadia HM, Scadden DT, Brander C.

AIDS. 2007 Jun 19;21(10):1245-52.

PMID:
17545700
6.

Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes.

Bihl F, Narayan M, Chisholm JV 3rd, Henry LM, Suscovich TJ, Brown EE, Welzel TM, Kaufmann DE, Zaman TM, Dollard S, Martin JN, Wang F, Scadden DT, Kaye KM, Brander C.

J Virol. 2007 May;81(9):4904-8. Epub 2007 Feb 28.

7.

Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses.

Bihl F, Frahm N, Di Giammarino L, Sidney J, John M, Yusim K, Woodberry T, Sango K, Hewitt HS, Henry L, Linde CH, Chisholm JV 3rd, Zaman TM, Pae E, Mallal S, Walker BD, Sette A, Korber BT, Heckerman D, Brander C.

J Immunol. 2006 Apr 1;176(7):4094-101.

8.

Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"

Bihl FK, Loggi E, Chisholm JV 3rd, Hewitt HS, Henry LM, Linde C, Suscovich TJ, Wong JT, Frahm N, Andreone P, Brander C.

J Transl Med. 2005 May 11;3(1):20.

Supplemental Content

Loading ...
Support Center